Disparities in Access to Transcatheter Aortic Valve Replacement in Major Metro Areas

JAMA Cardiology

EMBARGOED FOR RELEASE: 11 A.M. (ET), WEDNESDAY, NOVEMBER 17, 2021

Media advisory: The full study and editor’s note are linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time  https://jamanetwork.com/journals/jamacardiology/fullarticle/10.1001/jamacardio.2021.4641?guestAccessKey=34561b65-a1e0-4213-830a-850050fafce7&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=111721

 

What The Study Did: This analysis of Medicare claims data found that within major metropolitan areas with transcatheter aortic valve replacement (TAVR) programs, zip codes with higher proportions of Black and Hispanic patients and patients with greater socioeconomic disadvantages had lower rates of TAVR.

Authors: Ashwin S. Nathan, M.D., M.S., of the Hospital of the University of Pennsylvania in Philadelphia, is the corresponding author.

 

(doi:10.1001/jamacardio.2021.4641)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflicts of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.